Evidence map›Paper›PMID 25192902›Full record

SynthesisFamily practice2014

Multi-drug therapy in chronic condition multimorbidity: a systematic review.

Lucy Doos, Eyitope O Roberts, Nadia Corp, Umesh T Kadam

Open access · bronzeAbstract readSystematic Review
In one paragraph

Synthesis in Family practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Prevalence and impact of non-prescription medication misuse in the geriatric population.Exploratory research in clinical and social pharmacy · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Over the Counter Pain Medications Used by Adults: A Need for Pharmacist Intervention.International journal of environmental research and public health · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. An Atypical Case of Extreme Polypharmacy.Drug, healthcare and patient safety · 2022
    Article
  17. Multimorbidity in the Elderly: A Systematic Bibliometric Analysis of Research Output.International journal of environmental research and public health · 2021
    Review
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Lucy DoosNIHR Horizon Scanning Centre, Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK, l.doos@bham.ac.uk.
Eyitope O RobertsDepartment of Family Medicine, University of Calgary, Calgary, Alberta, Canada and.
Nadia CorpArthritis Research UK Primary Care Centre, Research Institute for Primary Care & Health Sciences and.
Umesh T KadamHealth Services Research Unit, Institute of Science and Technology in Medicine, Keele University, Stoke-on-Trent, UK.
Keele University · GBUniversity of Birmingham · GBUniversity of Calgary · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOlder populations often suffer from multimorbidity and guidelines for each condition are often associated with recommended drug therapy management. Yet, how different and specific multimorbidity is associated with number and type of multi-drug therapies in general populations is unknown.

aimThe aim of this systematic review was to synthesize the current evidence on patterns of multi-drug prescribing in family practice.

methodsA systematic review on six common chronic conditions: diabetes mellitus, cardiovascular disease, cerebrovascular disease, chronic obstructive pulmonary disease (COPD), osteoarthritis and depression was conducted, with a focus on studies which looked at any potential combination of two or more multimorbidity. Studies were identified from searches of MEDLINE, EMBASE, PsychINFO, the Allied and Complementary Medicine Database (AMED) and the Health Management Information Consortium (HMIC) databases from 1960 to 2013.

resultsA total of eleven articles were selected based on study criteria. Our review identified very few specific studies which had explicitly investigated the association between multimorbidity and multi-drug therapy. Relevant chronic conditions literature showed nine observational studies and two reviews of comorbid depression drug treatment. Most (seven) of the articles had focused on the chronic condition and comorbid depression and whether antidepressant management had been optimal or not, while four studies focused on other multimorbidities mainly heart failure, COPD and diabetes.

conclusionsVery few studies have investigated associations between specific multimorbidity and multi-drug therapy, and most currently focus on chronic disease comorbid depression outcomes. Further research needs to identify this area as key priority for older populations who are prescribed high levels of multiple drug therapy.

Indexed as

PolypharmacyAgedAged, 80 and overCardiovascular DiseasesCerebrovascular DisordersChronic DiseaseComorbidityDatabases, BibliographicDepressive DisorderDiabetes MellitusFamily PracticeHumansMiddle AgedOsteoarthritisPractice Guidelines as TopicPrevalenceChronic diseaseCOPDdepressiondrug therapymultimorbidityosteoarthritis.

Identifiers

PMID25192902
PMCPMC5942538
OpenAlexW2170673035

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.